Last reviewed · How we verify

NCT01804803: DIAMONDS

DIgital Assisted MONitoring for DiabeteS - I

Completed NA Last updated 4 June 2020
What this trial tests

NA trial testing Use of software-implemented glucometer for real-time collection and transmission of measured glucose values to remote server. in Diabetes Mellitus in 123 participants. Completed in 30 November 2017.

Timeline
9 September 2013
Primary endpoint
30 November 2017
30 November 2017

Quick facts

Lead sponsorUniversity of Bari
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment123
Start date9 September 2013
Primary completion30 November 2017
Estimated completion30 November 2017
Sites3 locations across Italy

Drugs / interventions tested

Conditions studied

Sponsor

University of Bari

Who can join

Adults 18 to 70, any sex, with Diabetes Mellitus. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study aims to validate the clinical efficacy of a telemedicine- and web-based system platform for Self-monitoring of blood glucose (SMBG) data transmission and analysis in terms of improved metabolic control, assessed by measuring changes in HbA1c, in insulin-treated diabetic patients. The system platform involves (i.) systematic (real-time and anywhere) transmission of SMBG data to a decision supported software (DSS)-assisted server, (ii.) web-based analysis of data, and (iii.) feedback on patients and medical staff to implement metabolic control. The expected outcome is that using this telemedicine-based system with transmission of SMBG data, web-based analysis of data and medical feedback to patients and medical team will improve glucose control in insulin-treated individuals with type 1 or type 2 diabetes mellitus.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. A telemedicine-based approach with real-time transmission of blood glucose data improves metabolic control in insulin-treated diabetes: the DIAMONDS randomized clinical trial.
    Di Molfetta S, Patruno P, Cormio S, Cignarelli A, et al · · 2022 · cited 8× · PMID 35476320 · DOI 10.1007/s40618-022-01802-w

Verify or expand the search:

Other recruiting trials for Diabetes Mellitus

Currently open trials in the same condition.

Other University of Bari trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT01804803.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing